{"title":"核壳多功能纤维垫工程蛛丝通过巨噬细胞极化加速慢性糖尿病伤口愈合。","authors":"Mercyjayapriya Jebakumar, Mohandass Pachaiyappan, Numbi Ramudu Kamini, Janani Radhakrishnan, Niraikulam Ayyadurai","doi":"10.1021/acsbiomaterials.5c00737","DOIUrl":null,"url":null,"abstract":"<p><p>Macrophage phenotypic switching from pro-inflammatory M1 to pro-regenerative M2 is impaired in chronic diabetic wounds, leading to excessive reactive oxygen species (ROS) production, poor angiogenesis, and decreased collagen deposition, thereby affecting the healing cascade. Development of multifunctional biomaterial with bioactive compounds to modulate the immune microenvironment and combat ROS, with the potential to facilitate angiogenesis and increase collagen deposition. Here, a novel combination therapy of silk DOPA-crisaborole conjugate (SDC, angiogenic and anti-inflammatory) and eugenol (Eu, antioxidant) has been devised to promote chronic wound healing. The core-shell electrospun fibrous mat has been fabricated with Eu in a polycaprolactone core (PCL-Eu) and SDC in a dextran shell (Dex-SDC), collectively termed Dex-SDC/PCL-Eu. In response to the acidic environment of chronic wounds, the dynamic benzoxaborole-catechol complex between crisaborole and silk DOPA cleaves, releasing crisaborole, while the matrix degradation of Dex-SDC/PCL-Eu over time enables the controlled release of Eu for 12 days. The initial release of crisaborole promotes polarization of M1 macrophages to M2 phenotype by significantly upregulating anti-inflammatory cytokine IL-10 and downregulating pro-inflammatory cytokine IL-6 gene expression in Dex-SDC/PCL-Eu-treated THP-1 cells compared to control. Subsequently, the sustained release of Eu mitigates oxidative damage. Dex-SDC/PCL-Eu fibers facilitate in vitro adhesion, migration, and proliferation of fibroblasts and endothelial cells as well as enhance endothelial tube formation. In the diabetic rat model, the Dex-SDC/PCL-Eu fibers reduce inflammatory granulation tissue and ulceration, while promoting neovascularization, complete re-epithelialization, and well-organized dermis and epidermis formation with uniform collagen deposition. Thus, the developed multifunctional Dex-SDC/PCL-Eu fibrous mat accelerates full-thickness skin wound healing and holds promise for the treatment of chronic diabetic wounds.</p>","PeriodicalId":8,"journal":{"name":"ACS Biomaterials Science & Engineering","volume":" ","pages":""},"PeriodicalIF":5.5000,"publicationDate":"2025-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Engineered Spider Silk in Core-Shell Multifunctional Fibrous Mat for Accelerated Chronic Diabetic Wound Healing via Macrophage Polarization.\",\"authors\":\"Mercyjayapriya Jebakumar, Mohandass Pachaiyappan, Numbi Ramudu Kamini, Janani Radhakrishnan, Niraikulam Ayyadurai\",\"doi\":\"10.1021/acsbiomaterials.5c00737\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Macrophage phenotypic switching from pro-inflammatory M1 to pro-regenerative M2 is impaired in chronic diabetic wounds, leading to excessive reactive oxygen species (ROS) production, poor angiogenesis, and decreased collagen deposition, thereby affecting the healing cascade. Development of multifunctional biomaterial with bioactive compounds to modulate the immune microenvironment and combat ROS, with the potential to facilitate angiogenesis and increase collagen deposition. Here, a novel combination therapy of silk DOPA-crisaborole conjugate (SDC, angiogenic and anti-inflammatory) and eugenol (Eu, antioxidant) has been devised to promote chronic wound healing. The core-shell electrospun fibrous mat has been fabricated with Eu in a polycaprolactone core (PCL-Eu) and SDC in a dextran shell (Dex-SDC), collectively termed Dex-SDC/PCL-Eu. In response to the acidic environment of chronic wounds, the dynamic benzoxaborole-catechol complex between crisaborole and silk DOPA cleaves, releasing crisaborole, while the matrix degradation of Dex-SDC/PCL-Eu over time enables the controlled release of Eu for 12 days. The initial release of crisaborole promotes polarization of M1 macrophages to M2 phenotype by significantly upregulating anti-inflammatory cytokine IL-10 and downregulating pro-inflammatory cytokine IL-6 gene expression in Dex-SDC/PCL-Eu-treated THP-1 cells compared to control. Subsequently, the sustained release of Eu mitigates oxidative damage. Dex-SDC/PCL-Eu fibers facilitate in vitro adhesion, migration, and proliferation of fibroblasts and endothelial cells as well as enhance endothelial tube formation. In the diabetic rat model, the Dex-SDC/PCL-Eu fibers reduce inflammatory granulation tissue and ulceration, while promoting neovascularization, complete re-epithelialization, and well-organized dermis and epidermis formation with uniform collagen deposition. Thus, the developed multifunctional Dex-SDC/PCL-Eu fibrous mat accelerates full-thickness skin wound healing and holds promise for the treatment of chronic diabetic wounds.</p>\",\"PeriodicalId\":8,\"journal\":{\"name\":\"ACS Biomaterials Science & Engineering\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":5.5000,\"publicationDate\":\"2025-09-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ACS Biomaterials Science & Engineering\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://doi.org/10.1021/acsbiomaterials.5c00737\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MATERIALS SCIENCE, BIOMATERIALS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Biomaterials Science & Engineering","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1021/acsbiomaterials.5c00737","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
Engineered Spider Silk in Core-Shell Multifunctional Fibrous Mat for Accelerated Chronic Diabetic Wound Healing via Macrophage Polarization.
Macrophage phenotypic switching from pro-inflammatory M1 to pro-regenerative M2 is impaired in chronic diabetic wounds, leading to excessive reactive oxygen species (ROS) production, poor angiogenesis, and decreased collagen deposition, thereby affecting the healing cascade. Development of multifunctional biomaterial with bioactive compounds to modulate the immune microenvironment and combat ROS, with the potential to facilitate angiogenesis and increase collagen deposition. Here, a novel combination therapy of silk DOPA-crisaborole conjugate (SDC, angiogenic and anti-inflammatory) and eugenol (Eu, antioxidant) has been devised to promote chronic wound healing. The core-shell electrospun fibrous mat has been fabricated with Eu in a polycaprolactone core (PCL-Eu) and SDC in a dextran shell (Dex-SDC), collectively termed Dex-SDC/PCL-Eu. In response to the acidic environment of chronic wounds, the dynamic benzoxaborole-catechol complex between crisaborole and silk DOPA cleaves, releasing crisaborole, while the matrix degradation of Dex-SDC/PCL-Eu over time enables the controlled release of Eu for 12 days. The initial release of crisaborole promotes polarization of M1 macrophages to M2 phenotype by significantly upregulating anti-inflammatory cytokine IL-10 and downregulating pro-inflammatory cytokine IL-6 gene expression in Dex-SDC/PCL-Eu-treated THP-1 cells compared to control. Subsequently, the sustained release of Eu mitigates oxidative damage. Dex-SDC/PCL-Eu fibers facilitate in vitro adhesion, migration, and proliferation of fibroblasts and endothelial cells as well as enhance endothelial tube formation. In the diabetic rat model, the Dex-SDC/PCL-Eu fibers reduce inflammatory granulation tissue and ulceration, while promoting neovascularization, complete re-epithelialization, and well-organized dermis and epidermis formation with uniform collagen deposition. Thus, the developed multifunctional Dex-SDC/PCL-Eu fibrous mat accelerates full-thickness skin wound healing and holds promise for the treatment of chronic diabetic wounds.
期刊介绍:
ACS Biomaterials Science & Engineering is the leading journal in the field of biomaterials, serving as an international forum for publishing cutting-edge research and innovative ideas on a broad range of topics:
Applications and Health – implantable tissues and devices, prosthesis, health risks, toxicology
Bio-interactions and Bio-compatibility – material-biology interactions, chemical/morphological/structural communication, mechanobiology, signaling and biological responses, immuno-engineering, calcification, coatings, corrosion and degradation of biomaterials and devices, biophysical regulation of cell functions
Characterization, Synthesis, and Modification – new biomaterials, bioinspired and biomimetic approaches to biomaterials, exploiting structural hierarchy and architectural control, combinatorial strategies for biomaterials discovery, genetic biomaterials design, synthetic biology, new composite systems, bionics, polymer synthesis
Controlled Release and Delivery Systems – biomaterial-based drug and gene delivery, bio-responsive delivery of regulatory molecules, pharmaceutical engineering
Healthcare Advances – clinical translation, regulatory issues, patient safety, emerging trends
Imaging and Diagnostics – imaging agents and probes, theranostics, biosensors, monitoring
Manufacturing and Technology – 3D printing, inks, organ-on-a-chip, bioreactor/perfusion systems, microdevices, BioMEMS, optics and electronics interfaces with biomaterials, systems integration
Modeling and Informatics Tools – scaling methods to guide biomaterial design, predictive algorithms for structure-function, biomechanics, integrating bioinformatics with biomaterials discovery, metabolomics in the context of biomaterials
Tissue Engineering and Regenerative Medicine – basic and applied studies, cell therapies, scaffolds, vascularization, bioartificial organs, transplantation and functionality, cellular agriculture